Erratum: Mood and affect disorders (Pediatrics in Review (2015) 36:2 (52-61) DOI:10.1542/pir.36-2-52);Mood and affect disorders

Pediatrics in Review

Volumn 36, Issue 2, 2015, Pages 52-61

  Tang, Michael H ^a,b   Pinsky, Elizabeth G ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID; ZIPRASIDONE;

ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHILD; CHILD PSYCHIATRY; CHILDHOOD MORTALITY; COGNITIVE THERAPY; CYCLOTHYMIA; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DISRUPTIVE MOOD DYSREGULATION DISORDER; DRUG DOSE REGIMEN; DRUG SAFETY; DSM-5; EPIDEMIOLOGICAL DATA; FAMILY THERAPY; HOMICIDE; HUMAN; MAJOR DEPRESSION; MANIA; MOOD DISORDER; MORBIDITY; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PATIENT HEALTH QUESTIONNAIRE 9; PEDIATRICIAN; PRIMARY MEDICAL CARE; PROGNOSIS; PSYCHODYNAMIC PSYCHOTHERAPY; PSYCHOSIS; PSYCHOTHERAPY; RISK ASSESSMENT; SELF INJECTION; SUBSTANCE USE; SUICIDE; ADOLESCENT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; MALE; MOOD DISORDERS; PRESCHOOL CHILD; PREVALENCE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MOOD DISORDERS; PREVALENCE;

EID: 84922365936     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.36-4-180     Document Type: Erratum

References (22)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
2. Perou R, Bitsko RH, Blumberg SJ, et al Centers for Disease Control and Prevention (CDC). Mental health surveillance among children-United States, 2005-2011. MMWR Surveill Summ. 2013 May 17;62(suppl 2):1-3 Google Scholar
3. Merikangas KR, He JP, Burstein M, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication - Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980-989 CrossRef Medline Web of Science Google Scholar
4. Patient Health Questionnaire-9 (PHQ-9). Bright Futures Tool and Resource Kit. http://brightfutures.aap.org/tool-and-resource-kit.html. Accessed July 13, 2014.
5. Center for Epidemiologic Studies Depression Scale for Children (CES-DC). Bright Futures Tool and Resource Kit. http://www.brightfutures.org/mentalhealth/pdf/professionals/bridges/ces-dc.pdf. Accessed July 13, 2014.
6. Gould MS, Marrocco FA, Kleinman M, et al. Evaluating iatrogenic risk of youth suicide screening programs: a randomized controlled trial. JAMA. 2005;293(13):1635-1643 CrossRef Medline Web of Science Google Scholar
7. Lewandowski RE, Acri MC, Hoagwood KE, et al. Evidence for the management of adolescent depression. Pediatrics. 2013;132(4):e996-e1009 Abstract/FREE Full Text
8. March J, Silva S, Petrycki S, et al Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807-820 CrossRef Medline Web of Science Google Scholar
9. March JS, Silva S, Petrycki S, et al. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007;64(10):1132-1143 CrossRef Medline Web of Science Google Scholar
10. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299(8):901-913 CrossRef Medline Google Scholar
11. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297(15):1683-1696 CrossRef Medline Web of Science Google Scholar
12. Isacsson G, Rich CL. Antidepressant drugs and the risk of suicide in children and adolescents. Paediatr Drugs. 2014;16(2):115-122 CrossRef Medline Google Scholar
13. Goldsmith M, Singh M, Chang K. Antidepressants and psychostimulants in pediatric populations: is there an association with mania? Paediatr Drugs. 2011;13(4):225-243 CrossRef Medline Google Scholar
14. Birmaher B, Brent D, Bernet W, et al AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1503-1526 CrossRef Medline Google Scholar
15. Emslie GJ, Kennard BD, Mayes TL, et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry. 2008;165(4):459-467 CrossRef Medline Web of Science Google Scholar
16. McClellan J, Kowatch R, Findling RL; Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(1):107-125 CrossRef Medline Google Scholar
17. Copeland WE, Angold A, Costello EJ, Egger H. Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. Am J Psychiatry. 2013;170(2):173-179 CrossRef Medline Web of Science Google Scholar
18. West AE, Pavuluri MN. Psychosocial treatments for childhood and adolescent bipolar disorder. Child Adolesc Psychiatr Clin N Am. 2009;18(2):471-482, x-xi CrossRef Medline Google Scholar
19. Geller B, Luby JL, Joshi P, et al. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry. 2012;69(5):515-528 CrossRef Medline Web of Science Google Scholar
20. Birmaher B, Axelson D, Goldstein B, et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry. 2009;166(7):795-804 CrossRef Medline Web of Science Google Scholar
21. Copeland WE, Shanahan L, Egger H, Angold A, Costello EJ. Adult diagnostic and functional outcomes of DSM-5 disruptive mood dysregulation disorder. Am J Psychiatry. 2014;171(6):668-674 CrossRef Medline Google Scholar
22. Axelson D, Findling RL, Fristad MA, et al. Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study. J Clin Psychiatry. 2012;73(10):1342-1350 CrossRef Medline Google Scholar